Dorzox T 5 Ml Eye Drop

(0 customer reviews)
Price range: $12.05 through $64.66

In Stock

Dorzox T 5 Ml Eye Drop

Price range: $12.05 through $64.66
In Stock
Secure
Checkout
Free
Shipping
30-Day
Returns
Quality
Guaranteed
Quantity
Safe Payment

All major cards & wallets accepted

Premium Quality

Tested to highest standards

24/7 Support

We're here whenever you need us

Money-Back Guarantee

30-day no questions asked

What Is Dorzox T 5 Ml Eye Drop?

Dorzox T 5 Ml Eye Drop is a prescription-only combination ophthalmic solution formulated as a clear, colourless-to-slightly-yellow sterile aqueous solution. The "T" in the brand name stands for the Timolol component — indicating the fixed-dose combination with Dorzolamide. Each millilitre of the solution contains:
  • Dorzolamide Hydrochloride — equivalent to Dorzolamide 2% w/v (20 mg per ml)
  • Timolol Maleate — equivalent to Timolol 0.5% w/v (5 mg per ml)
  The combination is the generic equivalent of Cosopt (MSD/Merck) — one of the most prescribed IOP-lowering combination eye drops in global ophthalmology practice. As a Sun Pharmaceuticals generic, Dorzox T provides the same clinically validated dual mechanism at a significantly more accessible price point, making long-term glaucoma therapy financially sustainable for patients who require ongoing daily IOP management. Patients looking to compare glaucoma eye drop options or explore the broader range of anti-glaucoma ophthalmic products can browse the eye care products collection at Ed Care Store.

What Is Dorzox T 5 Ml Eye Drop Used For?

Open-Angle Glaucoma (OAG) – Primary Indication

Open-angle glaucoma is the most common form of glaucoma — a progressive optic neuropathy in which chronic elevation of intraocular pressure damages the optic nerve fibres progressively, causing irreversible loss of visual field that begins peripherally and, if untreated, advances to central vision and blindness. It is called "open-angle" because the drainage angle between the iris and cornea remains anatomically open, yet aqueous humour drainage is impaired at the trabecular meshwork level, leading to IOP build-up. Dorzox T is specifically indicated for open-angle glaucoma in two clinical scenarios: as adjunct therapy in patients already using a topical beta-blocker whose IOP remains insufficiently controlled, and as monotherapy replacement in patients for whom beta-blocker monotherapy is contraindicated or has been deemed inadequate as a standalone approach. The combination of Dorzolamide + Timolol in a single bottle simplifies the treatment regimen and improves patient adherence compared to using two separate drop bottles.

Ocular Hypertension (OHT)

Ocular hypertension refers to elevated intraocular pressure (typically above 21 mmHg) without any associated optic nerve damage or visual field loss at the time of diagnosis. While not all patients with OHT develop glaucoma, statistically it is the most significant modifiable risk factor for glaucomatous optic nerve damage. The Ocular Hypertension Treatment Study (OHTS) demonstrated that IOP-lowering treatment significantly reduces the risk of progression to glaucoma. Dorzox T effectively lowers elevated IOP in ocular hypertension — protecting the optic nerve from future damage before irreversible vision loss occurs. For patients also managing nutritional eye health alongside glaucoma prevention, Macuchek Forte Capsule (Lutein, Zeaxanthin, Astaxanthin) offers complementary retinal antioxidant support available on the same platform.

Pseudoexfoliative Glaucoma

Pseudoexfoliative glaucoma (PXG) is a secondary open-angle glaucoma characterised by the deposition of flaky, dandruff-like fibrillar material on the anterior lens capsule, zonules, and trabecular meshwork — accelerating aqueous humour outflow obstruction and typically producing higher IOP elevations than primary open-angle glaucoma. Dorzox T's dual mechanism of reducing aqueous production via both a CAI and a beta-blocker makes it particularly effective in the higher IOP levels commonly seen in PXG.

How Does Dorzox T 5 Ml Eye Drop Work?

Dorzolamide – Carbonic Anhydrase Inhibitor (CAI)

Dorzolamide Hydrochloride is a topical sulfonamide carbonic anhydrase inhibitor (CAI) — the first CAI developed specifically for topical ophthalmic use. The enzyme carbonic anhydrase II (CAII) is abundantly expressed in the ciliary epithelium of the ciliary body — the ocular structure responsible for secreting aqueous humour into the posterior chamber. CAII catalyses the hydration of carbon dioxide to bicarbonate and hydrogen ions, and this reaction is essential for driving the active secretion of aqueous humour. By selectively inhibiting CAII in the ciliary epithelium, Dorzolamide reduces bicarbonate ion production and consequently slows the active secretion of aqueous humour into the posterior chamber. With less aqueous being produced, intraocular pressure decreases. This mechanism is complementary to — and operates via a completely different pathway from — the mechanism of Timolol, making the combination pharmacologically synergistic rather than simply additive.

Timolol – Non-Selective Beta-Adrenergic Blocker

Timolol Maleate is a non-selective beta-1 and beta-2 adrenergic receptor antagonist (beta-blocker) and was the first beta-blocker approved for topical ophthalmic use. In the eye, beta-adrenergic receptors are expressed on the ciliary epithelium, and their activation by circulating catecholamines (adrenaline/epinephrine) stimulates aqueous humour production. Timolol blocks these receptors, reducing sympathetic stimulation of aqueous secretion and thereby lowering IOP through a cAMP-mediated reduction in active fluid transport. Unlike Dorzolamide's CAI mechanism, Timolol also has a mild effect on increasing uveoscleral outflow — providing a secondary complementary pathway for IOP reduction. The combined IOP-lowering effect of both agents together produces a greater and more sustained reduction in IOP than either drug achieves at maximum monotherapy doses. For patients managing intraocular pressure with prostaglandin analogue eye drops, Careprost Eye Drops (Bimatoprost) — a prostaglandin analogue IOP-lowering drop — is also available on the same platform as an alternative or adjunct option under physician guidance.

How to Use Dorzox T 5 Ml Eye Drop Correctly

Proper instillation technique ensures maximum drug delivery to the eye and minimises systemic absorption through the nasolacrimal drainage system:
  • Wash your hands thoroughly with soap and water and dry completely before handling the bottle.
  • Check the dropper tip: Ensure the tip is not cracked, chipped, or contaminated. Do not use if the bottle seal is broken upon opening.
  • Contact lens removal: Remove soft contact lenses before instillation. The benzalkonium chloride preservative in Dorzox T can be absorbed by soft lenses and cause ocular irritation. Wait at least 15 minutes before reinserting lenses.
  • Head positioning: Tilt your head back gently and look upward toward the ceiling.
  • Create a pocket: Using your index finger, gently pull down the lower eyelid to form a small conjunctival pocket.
  • Instil one drop: Hold the bottle tip close to the eye (without touching it) and gently squeeze to release one drop into the lower conjunctival pocket. Do not blink vigorously after instillation.
  • Nasolacrimal occlusion: Immediately after instillation, press the inner corner of the eye (the nasolacrimal duct at the inner canthus) with your fingertip for 1 to 2 minutes. This is critical — it limits drainage of the drop into the nasal passage and systemic circulation, significantly reducing systemic beta-blocker absorption and associated cardiovascular side effects.
  • Close the eye gently for 1–2 minutes without squeezing — avoid blinking excessively.
  • Wipe away excess: Gently blot away any excess solution around the eye with a clean tissue.
  • Multiple eye drops: If using other ophthalmic medications concurrently, wait at least 10 minutes between each product to prevent dilution and ensure adequate contact time.
  • Recap and store: Replace the bottle cap tightly after every use.
 

Dorzox T Eye Drop Dosage Guidelines

Indication Dose Frequency Special Notes
Open-Angle Glaucoma (adults) 1 drop in affected eye(s) Twice daily — approx. 12 hrs apart Same time each morning and evening
Ocular Hypertension (adults) 1 drop in affected eye(s) Twice daily Maintain consistent schedule
Pseudoexfoliative Glaucoma 1 drop in affected eye(s) Twice daily as directed by ophthalmologist Regular IOP monitoring essential
Children ≥2 years 1 drop in affected eye(s) Twice daily — as prescribed Safety established ≥2 yrs; not for <2 yrs
Adjunct to other IOP drops 1 drop in affected eye(s) Twice daily 10-minute gap between different drops
  Important: Never instil a double dose to compensate for a missed one. If a dose is missed, instil it as soon as you remember — unless it is almost time for the next scheduled dose, in which case skip it and continue as normal. Dorzox T controls IOP but does not cure glaucoma — it must be used every day, including when symptoms are absent, to maintain continuous pressure control. Patients who also use a lubricant eye drop alongside Dorzox T for dry eye symptoms can explore Trehalube Eye Drop 10 Ml (Sodium Hyaluronate + Trehalose) — a preservative-free lubricant available on the same platform, to be administered at least 10 minutes apart from Dorzox T.

Key Benefits of Dorzox T 5 Ml Eye Drop

  • Synergistic Dual-Mechanism IOP Reduction: Dorzolamide and Timolol inhibit aqueous humour production via two pharmacologically independent pathways — CAI enzyme inhibition and beta-adrenergic blockade. This produces IOP reduction that exceeds the sum of either agent alone, achieving 30–35% IOP lowering in clinical studies.
  • Proven Neuroprotective Benefit: Every mmHg of sustained IOP reduction translates directly to a slower rate of retinal ganglion cell and optic nerve fibre loss — preserving visual field and protecting long-term vision in glaucoma patients.
  • Simplified Treatment Adherence: Combining two active agents in one bottle eliminates the need for separate instillation of a CAI and a beta-blocker — reducing dosing complexity, the number of daily drop applications, and improving treatment adherence significantly.
  • Well-Established Generic of Cosopt: Dorzox T is the Sun Pharmaceuticals generic of Cosopt — one of the most clinically validated IOP-lowering combinations in global ophthalmic practice — offering identical efficacy at a fraction of the branded cost.
  • Twice-Daily Convenience: Twice-daily dosing (morning and evening) fits naturally into daily routines and provides continuous 24-hour IOP control — including overnight, when IOP tends to peak in many glaucoma patients.
  • FDA-Aligned Sterile Formulation: Sun Pharmaceuticals' sterile, buffered, isotonic formulation meets rigorous quality standards — the same benchmark used for globally distributed ophthalmic solutions.
  • Suitable for Patients Intolerant to Beta-Blocker Monotherapy: For patients who cannot achieve target IOP on Timolol alone, Dorzox T's addition of Dorzolamide provides the necessary additional IOP reduction within the same twice-daily drop format — without adding a third separate medication.
  Patients using Dorzox T alongside a steroid eye ointment for co-existing anterior segment inflammation should explore Lotel Eye Ointment 5 Gm (Loteprednol Etabonate) — a retrometabolic soft steroid eye ointment with significantly reduced IOP-elevating risk compared to conventional ophthalmic steroids, also available on the same platform.

Common Side Effects of Dorzox T Eye Drop

Ocular Side Effects (Local)

  • Burning or stinging sensation upon instillation — the most commonly reported effect; usually brief and decreases with continued use
  • Bitter or unusual taste in the mouth immediately after instillation — caused by nasolacrimal drainage of the drop; reduced by pressing the inner corner of the eye after use
  • Transient blurred vision — occurs immediately after instillation; clears within a few minutes. Avoid driving until vision fully clears
  • Conjunctival redness or hyperaemia
  • Itching, watery eyes, or foreign body sensation
  • Eyelid irritation or contact dermatitis
  • Punctate keratitis — superficial corneal irregularity occasionally reported with long-term use
 

Systemic Side Effects (Due to Timolol Absorption)

Though topically applied, Timolol in Dorzox T can be absorbed through the nasolacrimal duct into the systemic circulation. Nasolacrimal occlusion after instillation dramatically reduces this risk. Systemic effects include:
  • Bradycardia (slowed heart rate) — the most important systemic Timolol effect; serious in patients with pre-existing cardiac conduction disorders
  • Bronchospasm — particularly dangerous in patients with asthma or reactive airway disease; Timolol's non-selective beta-blockade inhibits bronchodilatory beta-2 receptors
  • Hypotension — reduced systemic blood pressure, which can cause dizziness, lightheadedness, or fainting on standing
  • Fatigue, dizziness, or depression
  • Masking of hypoglycaemia symptoms — Timolol can mask tachycardia (rapid heart rate), an important early warning sign of hypoglycaemia in diabetic patients. Blood glucose monitoring should be maintained.
 

Who Should Not Use Dorzox T Eye Drop?

Dorzox T Eye Drop is contraindicated or requires special caution in:
  • Patients with asthma, severe COPD, or reactive airways disease: Timolol's non-selective beta-2 blockade can trigger life-threatening bronchospasm. This is an absolute contraindication in asthma patients.
  • Known sulfonamide (sulfa) allergy: Dorzolamide is a sulfonamide derivative — patients with documented hypersensitivity to sulfa drugs are at risk of cross-reactive allergic reactions
  • Second or third degree atrioventricular block, sinus bradycardia, or overt cardiac failure: Timolol's cardiac beta-1 blockade can worsen these conditions
  • Cardiogenic shock: Absolute contraindication due to beta-blocker cardiovascular depression
  • Severe hepatic impairment: Dorzolamide is not adequately studied in severe liver disease; use with caution
  • Severe renal impairment (CrCl < 30 ml/min): Dorzolamide and its active metabolite are excreted by the kidneys — impaired clearance elevates drug levels
  • Acute angle-closure glaucoma: Dorzox T has not been evaluated for acute angle-closure and is not a first-line treatment for this emergency. Angle-closure requires different management
  • Children under 2 years of age: Safety and efficacy not established below this age
  • Pregnancy and breastfeeding: Not recommended during pregnancy. Timolol is excreted in breast milk — do not use while breastfeeding without specialist advice
 

Key Drug Interactions

Interacting Drug / Class Nature of Interaction Clinical Action
Systemic Beta-Blockers (oral atenolol, metoprolol, propranolol) Additive beta-blockade — bradycardia, hypotension, heart block risk Monitor heart rate and BP closely; dose adjustments may be needed
Calcium Channel Blockers (verapamil, diltiazem) Additive cardiac conduction slowing with Timolol — risk of AV block and severe bradycardia Avoid combination if possible; monitor ECG if concurrent use unavoidable
Other Carbonic Anhydrase Inhibitors (oral acetazolamide) Additive CAI effect — increased risk of systemic side effects (electrolyte disturbances, metabolic acidosis) Avoid concurrent use of systemic and topical CAIs
Antidiabetic Drugs (insulin, oral hypoglycaemics) Timolol masks tachycardia warning sign of hypoglycaemia Frequent blood glucose monitoring; patient education on alternative hypoglycaemia symptoms
CYP2D6 Inhibitors (fluoxetine, quinidine, paroxetine) Impaired Timolol metabolism — elevated Timolol blood levels and enhanced systemic beta-blockade Monitor for bradycardia, hypotension; dose reduction may be needed
Clonidine (antihypertensive) Abrupt clonidine withdrawal while on beta-blocker can cause rebound hypertension Gradual clonidine tapering required; close BP monitoring
Other IOP-Lowering Eye Drops When combining with prostaglandin analogues or alpha-agonists, maintain 10 min intervals Space all eye drops at least 10 minutes apart; discuss combination therapy with ophthalmologist
 

Dorzox T vs Other IOP-Lowering Eye Drop Options

Understanding where Dorzox T sits within the anti-glaucoma treatment landscape helps patients and prescribers choose the most appropriate therapy:
Feature Dorzox T (Dorzox./Tim.) Careprost (Bimatoprost) Timolol 0.5% Alone Cosopt (Branded)
Active Ingredient(s) Dorzolamide 2% + Timolol 0.5% Bimatoprost 0.03% Timolol 0.5% Dorzolamide 2% + Timolol 0.5%
Mechanism CAI + Beta-Blocker Prostaglandin analogue Beta-Blocker only CAI + Beta-Blocker
IOP Reduction ~30–35% ~25–33% ~20–25% ~30–35%
Dosing Frequency Twice daily Once daily (evening) Twice daily Twice daily
Bronchospasm Risk ⚠ Yes (Timolol) ✗ None ⚠ Yes ⚠ Yes (Timolol)
Additional Effect Nil Eyelash growth (side effect) Nil Nil
Manufacturer Sun Pharma (Generic) Sun Pharma (Branded) Various MSD/Merck (Branded)
Cost Position ✓ Affordable Generic ✓ Affordable ✓ Very Affordable Premium Brand
  Patients who cannot use beta-blocker-containing drops due to asthma or cardiac contraindications may require a prostaglandin analogue as monotherapy. Bimat Eye Drops (Bimatoprost) — a beta-blocker-free prostaglandin analogue available on the same platform — is suitable for these patients under ophthalmologist guidance.

Storage Instructions for Dorzox T 5 Ml Eye Drop

  • Store between 15°C and 30°C — at room temperature in a cool, dry location away from heat sources and direct sunlight
  • Do not refrigerate or freeze — extreme cold can compromise solution clarity and dropper valve function
  • Keep the bottle cap tightly closed when not in use to maintain sterility and prevent evaporation
  • Protect from light — store in the original carton until ready to use
  • Keep out of reach of children and pets
  • Discard the bottle 28 days after first opening, even if product remains — used bottles are vulnerable to microbial contamination
  • Do not use if the solution has changed colour or appears cloudy — discard and obtain a fresh bottle
  • Check the expiry date on the bottle and outer carton before use — do not use expired eye drops
 

Why Order Dorzox T 5 Ml Eye Drop from Ed Care Store?

Ed Care Store (edcarestore.com) is a trusted online healthcare pharmacy making quality-assured ophthalmic and general health medicines accessible to patients. When you purchase Dorzox T 5 Ml Eye Drop through Ed Care Store, you can rely on:
  • Authentic Sun Pharmaceuticals Products: All Dorzox T eye drops are sourced from verified supply channels — Sun Pharma-manufactured, GMP-compliant, and genuine. No counterfeits, no compromises.
  • Discreet, Tamper-Evident Delivery: Orders are dispatched in plain, secure packaging — your health privacy is fully protected from checkout to doorstep.
  • Competitive Generic Pricing: Access to the clinically validated Dorzolamide + Timolol combination at a fraction of branded Cosopt pricing — making daily long-term glaucoma management financially accessible.
  • Complete Eye Care Range: Alongside Dorzox T, the platform stocks a full range of ophthalmic products. Patients building a comprehensive eye care regimen can explore the complete eye care products range for lubricants, nutritional supplements, steroid ointments, and additional IOP-lowering options.
  • Men's Health Products Available: Men managing concurrent health conditions alongside glaucoma can access Kamagra Gold 100 Mg and other men's health products through the same trusted platform.
  • Health Education Resources: Visit the Ed Care Store health blog for informational content on eye health, treatment comparisons, and general wellness topics.
Glaucoma demands lifelong daily vigilance — and Dorzox T 5 Ml Eye Drop provides the dual-mechanism IOP control necessary to protect your optic nerve, preserve your visual field, and maintain your quality of life. Manufactured by Sun Pharmaceuticals to the highest international standards, and available through Ed Care Store at genuinely competitive pricing, Dorzox T makes effective glaucoma management both clinically reliable and financially sustainable. Disclaimer: The information on this page is for educational purposes only and does not substitute professional ophthalmic or medical advice, diagnosis, or treatment. Dorzox T 5 Ml Eye Drop is a prescription-only medicine. Always consult a qualified ophthalmologist before starting, adjusting, or stopping any glaucoma medication. Never self-diagnose or self-treat glaucoma. Ed Care Store stocks products exclusively from verified, licensed pharmaceutical manufacturers.
Dorzox T 5 Ml Eye Drop 1 Eye Drop, 3 Eye Drop, 6 Eye Drop
We offer free standard shipping on all orders. Orders are processed within 1-2 business days and typically arrive within 5-7 business days.
We accept returns within 30 days of purchase. Items must be in original condition with tags attached.
Yes! All our products come with a comprehensive warranty against defects in materials or workmanship.
Dorzox T 5 Ml Eye Drop
$12.05 – $64.66Price range: $12.05 through $64.66
Product zoom
EdCareStore Footer Image

Address
5954 Old Cove Heath Rd Eupora, Mississippi(MS), 39744

US Call/Text
+1 (914) 999-2631

Email
support@edcarestore.com

Trending Products

Vardenafil

Blue Pill

Tadalafil

Oral ED Jelly

Bimatoprost

Shop by category

Shop All

Men’s Health

Women’s Health

Eye Care

Asthma

Diabetes

Company

About Us

Reviews

Medicine Policy

Shipping Policy

Communication Policy

Disclaimer Policy

User guide

Indian Pharmacies

Protect Yourself

Regulated Medicine

Returns & Exchanges

Safe and Secure Shopping

FAQs

Copyright © 2026 Edcarestore | All Rights Reserved

Request Your Free Sample

Fill out the form below and our pharmacist will get in touch!

Please select an option
Full name is required
Valid phone number is required
Valid email address is required
Please describe the sample you're looking for

Thank You!

Your free sample request has been received.

Due to high demand, our pharmacist will reach out to you within the next 3-4 business days.